{"entity":{"type":"insider","cik":"0001363558","url":"/insider/0001363558","json_url":"/insider/0001363558.json","name":"Collard Craig A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":12,"first":"2009-07-30","last":"2023-11-17","span_basis":"filed_date"},"name_variants":[{"name":"Collard Craig A","source":"filing","n_filings":12,"first_seen":"2009-07-30","last_seen":"2023-11-17"}],"transactions":[{"id":8023741,"accession":"0001209191-23-055664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-055664","line_url":"/filing/0001209191-23-055664#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":0.9198,"price_display":"0.92","price_state":"stated","total_value":137970.0,"total_display":"137,970.00","total_whole":"137,970","shares_owned_after":186496.0,"shares_owned_after_display":"186,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":6745823,"accession":"0001104659-22-103243","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-103243","line_url":"/filing/0001104659-22-103243#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"TerrAscend Corp.","issuer_ticker":"TRSSF","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":420866.0,"shares_owned_after_display":"420,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-27","scope":"insider"},{"id":6418850,"accession":"0001104659-22-102917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-102917","line_url":"/filing/0001104659-22-102917#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"TerrAscend Corp.","issuer_ticker":"TRSSF","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120000.0,"shares_display":"120,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":360866.0,"shares_owned_after_display":"360,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-26","scope":"insider"},{"id":6757084,"accession":"0001385508-22-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-22-000076","line_url":"/filing/0001385508-22-000076#line-2","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4037.0,"shares_display":"4,037","price_per_share":10.936,"price_display":"10.94","price_state":"stated","total_value":44148.632,"total_display":"44,148.63","total_whole":"44,149","shares_owned_after":53822.0,"shares_owned_after_display":"53,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-13","filed_date":"2022-06-13","scope":"insider"},{"id":6757080,"accession":"0001385508-22-000076","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000076","line_url":"/filing/0001385508-22-000076#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1663.0,"shares_display":"1,663","price_per_share":11.496,"price_display":"11.50","price_state":"stated","total_value":19117.848,"total_display":"19,117.85","total_whole":"19,118","shares_owned_after":49785.0,"shares_owned_after_display":"49,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-10","filed_date":"2022-06-13","scope":"insider"},{"id":6835237,"accession":"0001385508-22-000061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000061","line_url":"/filing/0001385508-22-000061#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27150.0,"shares_display":"27,150","price_per_share":13.54,"price_display":"13.54","price_state":"stated","total_value":367611.0,"total_display":"367,611.00","total_whole":"367,611","shares_owned_after":48122.0,"shares_owned_after_display":"48,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":6114455,"accession":"0001385508-22-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000058","line_url":"/filing/0001385508-22-000058#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3689.0,"shares_display":"3,689","price_per_share":10.49,"price_display":"10.49","price_state":"stated","total_value":38697.61,"total_display":"38,697.61","total_whole":"38,698","shares_owned_after":20972.0,"shares_owned_after_display":"20,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-13","filed_date":"2022-05-16","scope":"insider"},{"id":5501234,"accession":"0001209191-21-066860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-066860","line_url":"/filing/0001209191-21-066860#line-2","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7899.0,"shares_display":"7,899","price_per_share":23.085,"price_display":"23.08","price_state":"stated","total_value":182348.415,"total_display":"182,348.42","total_whole":"182,348","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-24","scope":"insider"},{"id":5501231,"accession":"0001209191-21-066860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066860","line_url":"/filing/0001209191-21-066860#line-1","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5601.0,"shares_display":"5,601","price_per_share":22.945,"price_display":"22.94","price_state":"stated","total_value":128514.945,"total_display":"128,514.94","total_whole":"128,515","shares_owned_after":5601.0,"shares_owned_after_display":"5,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-23","filed_date":"2021-11-24","scope":"insider"},{"id":4299633,"accession":"0001385508-21-000131","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-21-000131","line_url":"/filing/0001385508-21-000131#line-3","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":18.13,"price_display":"18.13","price_state":"stated","total_value":45325.0,"total_display":"45,325.00","total_whole":"45,325","shares_owned_after":16077.0,"shares_owned_after_display":"16,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4445284,"accession":"0001385508-21-000126","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-21-000126","line_url":"/filing/0001385508-21-000126#line-1","is_derivative":false,"issuer_cik":"0001363558","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001363558","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9577.0,"shares_display":"9,577","price_per_share":18.18,"price_display":"18.18","price_state":"stated","total_value":174109.86,"total_display":"174,109.86","total_whole":"174,110","shares_owned_after":13577.0,"shares_owned_after_display":"13,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-10","filed_date":"2021-09-13","scope":"insider"},{"id":2705125,"accession":"0001209191-12-021304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-021304","line_url":"/filing/0001209191-12-021304#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1443913.0,"shares_display":"1,443,913","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":9024456.25,"total_display":"9,024,456.25","total_whole":"9,024,456","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-04-03","filed_date":"2012-04-03","scope":"insider"},{"id":7352822,"accession":"0001209191-10-061781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-061781","line_url":"/filing/0001209191-10-061781#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":385000.0,"shares_display":"385,000","price_per_share":6.02,"price_display":"6.02","price_state":"stated","total_value":2317700.0,"total_display":"2,317,700.00","total_whole":"2,317,700","shares_owned_after":3011138.0,"shares_owned_after_display":"3,011,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-16","filed_date":"2010-12-20","scope":"insider"},{"id":5787304,"accession":"0001209191-09-038193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-038193","line_url":"/filing/0001209191-09-038193#line-1","is_derivative":false,"issuer_cik":"0001145404","issuer_name":"CORNERSTONE THERAPEUTICS INC","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001145404","owner_cik":"0001363558","owner_name":"Collard Craig A","owner_display_name":"Collard Craig A","owner_url":"/insider/0001363558","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250000.0,"shares_display":"1,250,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":6875000.0,"total_display":"6,875,000.00","total_whole":"6,875,000","shares_owned_after":3396138.0,"shares_owned_after_display":"3,396,138","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-28","filed_date":"2009-07-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"HERON THERAPEUTICS, INC. /DE/","url":"/issuer/0000818033","role":"Director, Officer (Chief Executive Officer)","n_filings":1,"first_seen":"2023-11-17","last_seen":"2023-11-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001778129","name":"TerrAscend Corp.","url":"/issuer/0001778129","role":"Director","n_filings":2,"first_seen":"2022-09-26","last_seen":"2022-09-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Director","n_filings":5,"first_seen":"2021-09-13","last_seen":"2022-06-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Director","n_filings":1,"first_seen":"2021-11-24","last_seen":"2021-11-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001145404","name":"CORNERSTONE THERAPEUTICS INC","url":"/issuer/0001145404","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":3,"first_seen":"2009-07-30","last_seen":"2012-04-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001363558","retrieved_at":"2026-08-27T06:30:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}